The Patent Finder

ADC Therapeutics S.A.

Also on record
Records under this name other than the patents ADC Therapeutics S.A. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 11 patents it holds.

Back to ADC Therapeutics S.A.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 10,736,903Pyrrolobenzodiazepine-Anti-Psma Antibody Conjugates
now held by MedImmune Limited
In force
 · High confidence
In forceHigh confidence
US 10,780,181Pyrrolobenzodiazepine-Antibody Conjugates
now held by MedImmune Limited
In force
 · High confidence
In forceHigh confidence
US 10,799,596Pyrrolobenzodiazepine-Antibody Conjugates
now held by MedImmune Limited
In force
 · High confidence
In forceHigh confidence
US 11,771,775Pyrrolobenzodiazepine-Antibody Conjugates
now held by MedImmune Limited
In force
 · High confidence
In forceHigh confidence
US 11,779,650Pyrrolobenzodiazepine-Antibody Conjugates
now held by MedImmune Limited
In force
 · Medium confidence
In forceMedium confidence
US 9,950,078Pyrrolobenzodiazepine-Antibody Conjugates
now held by MedImmune Limited
In force
 · Medium confidence
In forceMedium confidence
US 10,544,223Combination Therapy with an Anti-Axl Antibody-Drug Conjugate
now held by MedImmune Limited
In force
 · High confidence
In forceHigh confidence
US 11,813,335Pyrrolobenzodiazepine-Antibody Conjugates
now held by MedImmune Limited
In force
 · High confidence
In forceHigh confidence
US 11,318,211Dosage Regimes for the Administration of an ANTI-CD19 Adc
now held by MedImmune Limited
In force
 · High confidence
In forceHigh confidence
US 11,938,192Dosage Regimes for the Administration of an ANTI-CD19 Adc
now held by MedImmune Limited
In force
 · Medium confidence
In forceMedium confidence
10 of 57 records shown.
Pro members see all 57.
Pro members: see all 57 records
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited